Citation Impact
Citing Papers
Prospective Randomized Trial of Docetaxel Versus Best Supportive Care in Patients With Non–Small-Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy
2000 Standout
Topoisomerase I levels in the NCI-60 cancer cell line panel determined by validated ELISA and microarray analysis and correlation with indenoisoquinoline sensitivity
2009
Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update
2011 Standout
Palonosetron in combination with 1-day versus 3-day dexamethasone for prevention of nausea and vomiting following moderately emetogenic chemotherapy: a randomized, multicenter, phase III trial
2010
From stress to inflammation and major depressive disorder: A social signal transduction theory of depression.
2014 Standout
Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline
2015
Platinum-based chemotherapy in metastatic breast cancer: current status
2003
Rationale and techniques of intra-operative hyperthermic intraperitoneal chemotherapy
2001
8-Year Follow-up of Randomized Trial: Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy in Patients with Peritoneal Carcinomatosis of Colorectal Cancer
2008 Standout
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2014 Standout
Depression and cancer mortality: a meta-analysis
2010
Perspectives on cancer therapy-induced mucosal injury
2004 Standout
Mesoporous silica nanoparticles in biomedical applications
2012 StandoutNobel
High- versus low-dose levo-leucovorin as a modulator of 5-fluorouracil in advanced colorectal cancer: A ‘GISCAD’ phase III study
1997
Systemic chemotherapy for hepatocellular carcinoma in non-cirrhotic liver: A retrospective study
2009
Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies
2011 Standout
Influence of psychological coping on survival and recurrence in people with cancer: systematic review
2002
Overview of the efficacy of cetuximab in recurrent and/or metastatic squamous cell carcinoma of the head and neck in patients who previously failed platinum‐based therapies
2008
The cancer stem cell paradigm: a new understanding of tumor development and treatment
2010
Clinical aspects of altered glycosylation of glycoproteins in cancer
1999
Aprepitant in adolescent patients for prevention of chemotherapy‐induced nausea and vomiting: A randomized, double‐blind, placebo‐controlled study of efficacy and tolerability
2008
High-performance liquid chromatographic methods for the determination of topoisomerase II inhibitors
2001
Esophageal Cancer
2003 Standout
Clinical applications of quinone-containing alkylating agents
2000
Chemotherapy-induced peripheral neurotoxicity (CIPN): An update
2011
Social Relationships and Mortality Risk: A Meta-analytic Review
2010 Standout
Glycans in cancer and inflammation — potential for therapeutics and diagnostics
2005 StandoutNobel
Second Cancers Among 40 576 Testicular Cancer Patients: Focus on Long-term Survivors
2005 Standout
Social (Un)distancing: Teammate Interactions, Athletic Identity, and Mental Health of Student-Athletes During the COVID-19 Pandemic
2020 Standout
Pegylated liposomal doxorubicin and gemcitabine in patients with advanced hepatocellular carcinoma
2010
Loneliness in the general population: prevalence, determinants and relations to mental health
2017 Standout
Cellular processing of platinum anticancer drugs
2005 Standout
Treatment of nausea and vomiting: Gaps in our knowledge
2006
Oesophageal carcinoma
2013 Standout
Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study
1998 Standout
2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours
2010 Standout
Chemotherapy-Induced Nausea and Vomiting
2008 Standout
High-Voltage Electrical Pulses in Oncology: Irreversible Electroporation, Electrochemotherapy, Gene Electrotransfer, Electrofusion, and Electroimmunotherapy
2020 Standout
Second-Line Chemotherapy with 96-Hour Infusional Paclitaxel in Refractory Non-Small Cell Lung Cancer: Report of a Phase II Trial
1999
Increasing dose intensity of cisplatin-etoposide in advanced nonsmall cell lung carcinoma
1999
Paclitaxel and carboplatin in combination in the treatment of advanced non-small-cell lung cancer: a phase II toxicity, response, and survival analysis.
1995
Therapy for thymic epithelial tumors: a clinical study of 1,320 patients from Japan
2003 Standout
Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves
2012 Standout
Analysis of anticancer drugs: A review
2011 Standout
Oxidative mechanisms in the toxicity of metal ions
1995 Standout
Dependable social relationships predict overall survival in Stages II and III breast carcinoma patients
2005
Systemic Therapy for Non–clear Cell Renal Cell Carcinomas: A Systematic Review and Meta-analysis
2014
Platinum Compounds in the Treatment of Advanced Breast Cancer
2001
Chemistry in living systems
2005 StandoutNobel
The cancer stem cell: premises, promises and challenges
2011 Standout
Effect of Duloxetine on Pain, Function, and Quality of Life Among Patients With Chemotherapy-Induced Painful Peripheral Neuropathy
2013 Standout
Symptom relief with MVP (mitomycin C, vinblastine and cisplatin) chemotherapy in advanced non-small-cell lung cancer
1995
Chemotherapy-induced nausea and vomiting: ESMO Clinical Recommendations for prophylaxis
2008
Cisplatin in cancer therapy: Molecular mechanisms of action
2014 Standout
An Assessment of Methods to Combine Published Survival Curves
2000
Do all patients with advanced non-small-cell lung cancer benefit from cisplatin-based combination therapy?
2001
Metabolic selection of glycosylation defects in human cells
2001 StandoutNobel
Comparison of Four Chemotherapy Regimens for Advanced Non–Small-Cell Lung Cancer
2002 Standout
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2018 Standout
A survey of metastatic central nervous system tumors to cervical lymph nodes
2010
Experimental disclosure and its moderators: A meta-analysis.
2006 Standout
Renal cell carcinoma
2017 Standout
The Lycopodium alkaloids
2004 Standout
Fluorouracil, doxorubicin, and mitomycin combination versus PELF chemotherapy in advanced gastric cancer: a prospective randomized trial of the Italian Oncology Group for Clinical Research.
1994
Amplification of doxorubicin mutagenicity by cupric ion
1992
S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial
2008 Standout
Anxiety and depression after cancer diagnosis: Prevalence rates by cancer type, gender, and age
2012 Standout
Chemotherapy of gastric cancer
1988
Duration of Chemotherapy in Advanced Non–Small-Cell Lung Cancer: A Randomized Trial of Three Versus Six Courses of Mitomycin, Vinblastine, and Cisplatin
2001
The pharmacology and clinical uses of tamoxifen
1984
Social isolation, loneliness, and all-cause mortality in older men and women
2013 Standout
Head and Neck Cancer
2020 Standout
Nonsurgical management of malignant thymoma
1999
Antitumor Antibiotics: Bleomycin, Enediynes, and Mitomycin
2005 Standout
DNA Topoisomerase I Inhibitors: Chemistry, Biology, and Interfacial Inhibition
2009 Standout
Chemotherapy and supportive care versus supportive care alone for advanced non-small cell lung cancer
2008
Dissemination and publication of research findings: an updated review of related biases
2010 Standout
Mitomycin, Ifosfamide, and Cisplatin in Unresectable Non–Small-Cell Lung Cancer: Effects on Survival and Quality of Life
1999
Chemotherapy for advanced gastric cancer
2017 Standout
Safety of cisplatin combined with continuous 5-FU versus bolus 5-FU and leucovorin, in metastatic gastrointestinal cancer (FFCD 9404 randomised trial).
2006
A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules
2015 Standout
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
2014 Standout
Anticholinesterase effects of huperzine A, E2020, and tacrine in rats.
1998
American Society of Clinical Oncology Guideline for Antiemetics in Oncology: Update 2006
2006
Radiation Therapy for Breast Cancer and Increased Risk for Esophageal Carcinoma
1998
Phase III Randomized Controlled Trial Comparing the Survival of Patients With Unresectable Hepatocellular Carcinoma Treated With Nolatrexed or Doxorubicin
2007
Phase II study with the combination etoposide, doxorubicin, and cisplatin in advanced measurable gastric cancer.
1989
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Loneliness and Social Isolation as Risk Factors for Mortality
2015 Standout
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial
2016 Standout
Nature and Health
2014 Standout
Second-line chemotherapy for non-small cell lung cancer
2002
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout
Works of G. Cartei being referenced
Vinorelbine, bleomycin and methotrexate as a salvage therapy for patients with head and neck squamous carcinoma in relapse after cisplatin/fluorouracil
1998
Oral 5-Fluorouracil in Squamous Cell Carcinoma of the Skin in the Aged
2000
Pharmacokinetics of intraperitoneal hyperthermic perfusion with mitoxantrone in ovarian cancer
2000
Cisplatin-Cyclophosphamide-Mitomycin Combination Chemotherapy With Supportive Care Versus Supportive Care Alone for Treatment of Metastatic Non-Small-Cell Lung Cancer
1993
Psychosocial Factors and Breast Cancer: A 6-Year Italian Follow-Up Study
1997
Phase II trial of 5-fluorouracil and the natural l isomer of folinic acid in the treatment of advanced colorectal carcinoma
1994
Metastatic oligodendrogliomas: a review of the literature and case report
2008
Topoisomerase I, IIα and IIβ mRNA expression in peripheral blood mononuclear cells of patients with solid tumor: preliminary results
2006
In vitro basis for schedule-dependent interaction between gemcitabine and topoisomerase-targeted drugs in the treatment of colorectal cancer
2006
Gemcitabine and liposomal doxorubicin in biliary and hepatic carcinoma (HCC) chemotherapy: preliminary results and review of the literature
2006
A phase I-II study of liposomal doxorubicin (LD) in the treatment of hepatocellular carcinoma (HCC) not suitable for loco-regional therapy
2005
Second primary tumours (SPTs) after chemotherapy.
1996
A phase II study of gemcitabine at fixed infusion rate of 10 mg/m2/min with or without immunotherapy in advanced renal cancer.
2008
Detection of Five Circulating Antigens in Patients with Head and Neck Squamous Cell Carcinoma
1989
FAM2 Regimen in Disseminated Gastric Cancer
1984
Tamoxifen Treatment for Advanced Renal Cell Cancer
1980
Phase II study of cisplatin, 5-FU, and allopurinol in advanced esophageal cancer.
1986
Chemotherapy of invasive or metastatic thymoma: report of 11 cases.
1984
Analysis of topoisomerase (TOP) expression in peripheral blood mononuclear cell (PBMCs) from patients (PTS) undergoing chemotherapy (CHT) for solid tumors( ST)
2004
Serum Copper Level in Non-Hodgkin's Lymphomas
1982
[Cyclophosphamide, adriamycin and platinum (CAP) in the preoperative neoadjuvant phase and the therapy phase].
1986